Mediators of Inflammation
Volume 2009 (2009), Article ID 269541, 7 pages
doi:10.1155/2009/269541
Research Article

The Imbalance in Serum Concentration of Th-1- and Th-2-Derived Chemokines as One of the Factors Involved in Pathogenesis of Atopic Dermatitis

1Department of Dermatology, Medical University of Lodz, 94-017 Lodz, Poland
2Department of Pediatrics and Allergy, Medical University of Lodz, 90-153 Lodz, Poland
3Division of Internal Medicine, Asthma and Allergy, Medical University of Lodz, 93-036 Lodz, Poland

Received 25 March 2009; Accepted 15 May 2009

Academic Editor: Vera L. Petricevich

Copyright © 2009 Joanna Narbutt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Y. M. Leung, R. A. Nicklas, J. T. Li, et al., “Disease management of atopic dermatitis: an updated practice parameter,” Annals of Allergy, Asthma and Immunology, vol. 93, no. 3, supplement 2, pp. S1–S21, 2004.
  2. M. Boguniewicz, L. F. Eichenfield, and T. Hultsch, “Current management of atopic dermatitis and interruption of the atopic march,” Journal of Allergy and Clinical Immunology, vol. 112, no. 6, supplement 1, pp. S140–S150, 2003. View at Publisher · View at Google Scholar · View at PubMed
  3. N. Novak and T. Bieber, “Allergic and nonallergic forms of atopic diseases,” Journal of Allergy and Clinical Immunology, vol. 112, no. 2, pp. 252–262, 2003. View at Publisher · View at Google Scholar
  4. C.-W. Jeong, K.-S. Ahnt, N.-K. Rho, et al., “Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR,” Clinical & Experimental Allergy, vol. 33, no. 12, pp. 1717–1724, 2003. View at Publisher · View at Google Scholar
  5. D. Y. M. Leung and T. Bieber, “Atopic dermatitis,” The Lancet, vol. 361, no. 9352, pp. 151–160, 2003. View at Publisher · View at Google Scholar · View at PubMed
  6. E. C. Butcher and L. J. Picker, “Lymphocyte homing and hemostasis,” Science, vol. 272, p. 60, 1996.
  7. J. J. Campbell and E. C. Butcher, “Chemokines in tissue-specific and micro environment-specific lymphocyte homing,” Current Opinion in Immunology, vol. 12, p. 336, 2000.
  8. A. Zlotnik, J. Morales, and J. A. Hedrick, “Recent advances in chemokines and chemokine receptors,” Critical Reviews in Immunology, vol. 19, no. 1, pp. 1–47, 1999.
  9. E. J. Kunkel, J. Boisvert, K. Murphy, et al., “Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes,” American Journal of Pathology, vol. 160, no. 1, pp. 347–355, 2002.
  10. Y. Reiss, A. E. Proudfoot, C. A. Power, J. J. Campbell, and E. C. Butcher, “CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneoius T cell-attracting chemokine (CTACK) in lymphocytes trafficking to inflamed skin,” Journal of Experimental Medicine, vol. 194, p. 1541, 2001.
  11. T. Kakinuma, K. Nakamura, M. Wakugawa, et al., “Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity,” Journal of Allergy and Clinical Immunology, vol. 107, no. 3, pp. 535–541, 2001. View at Publisher · View at Google Scholar · View at PubMed
  12. T. Kakinuma, K. Nakamura, M. Wakugawa, et al., “Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis,” Clinical & Experimental Immunology, vol. 127, no. 2, pp. 270–273, 2002. View at Publisher · View at Google Scholar
  13. Y. Shimada, K. Takehara, and S. Sato, “Both Th-2 and Th1 chemokines (TARC/CCL-17, MDC/CCL-22 and MIG/CXCL-9) are elevated in sera from patients with atopic dermatitis,” Journal of Dermatological Science, vol. 34, p. 201, 2004.
  14. J. Nakazato, M. Kishida, R. Kuroiwa, J. Fujiwara, M. Shimoda, and N. Shinomiya, “Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis,” Pediatric Allergy and Immunology, vol. 19, no. 7, pp. 605–613, 2008. View at Publisher · View at Google Scholar · View at PubMed
  15. D.-S. Park and Y.-H. Youn, “Clinical significance of serum interleukin-18 concentration in the patients with atopic dermatitis,” The Korean Journal of Laboratory Medicine, vol. 27, no. 2, pp. 128–132, 2007. View at Publisher · View at Google Scholar
  16. M. Aral, O. Arican, M. Gul, et al., “The relationship between serum levels of total IgE, IL-18, IL-12, IFN-gamma and disease severity in children with atopic dermatitis,” Mediators of Inflammation, vol. 2006, p. 73098, 2006.
  17. J. M. Hanifin and G. Rajka, “Diagnostic features of atopic dermatitis,” Acta Dermatol Venerol, vol. 92, p. 44, 1980.
  18. A. P. Oranje, E. J. Glazenburg, A. Wolkerstorfer, and F. B. de Waard-van der Spek, “Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score,” British Journal of Dermatology, vol. 157, no. 4, pp. 645–648, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. M. P. Schön, T. M. Zollner, and W.-H. Boehncke, “The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders,” Journal of Investigative Dermatology, vol. 121, no. 5, pp. 951–962, 2003. View at Publisher · View at Google Scholar · View at PubMed
  20. B. Homey, H. Alenius, A. Müller, et al., “CCL27-CCR10 interactions regulate T cell-mediated skin inflammation,” Nature Medicine, vol. 8, no. 2, pp. 157–165, 2002. View at Publisher · View at Google Scholar · View at PubMed
  21. L. Chen, S.-X. Lin, R. Agha-Majzoub, L. Overbergh, C. Mathieu, and L. S. Chan, “CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model,” International Immunology, vol. 18, no. 8, pp. 1233–1242, 2006. View at Publisher · View at Google Scholar · View at PubMed
  22. D. Hijnen, M. de Bruin-Weller, B. Oosting, et al., “Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis,” Journal of Allergy and Clinical Immunology, vol. 113, no. 2, pp. 334–340, 2004.
  23. K. L. E. Hon, T. F. Leung, K. C. Ma, A. M. Li, Y. Wong, and T. F. Fok, “Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children,” Clinical and Experimental Dermatology, vol. 29, no. 3, pp. 293–296, 2004.
  24. K. Jahnz-Rozyk, T. Targowski, E. Paluchowska, W. Owczarek, and A. Kucharczyk, “Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis,” Allergy, vol. 60, no. 5, pp. 685–688, 2005. View at Publisher · View at Google Scholar · View at PubMed
  25. K. L. Hon, M. C. Lam, T. F. Leung, et al., “Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?” International Journal of Dermatology, vol. 46, no. 12, pp. 1258–1262, 2007.
  26. T. Oyama, S. Miura, C. Watanabe, et al., “CXCL12 and CCL20 play a significant role in mucosal T-lymphocyte adherence to intestinal microvessels in mice,” Microcirculation, vol. 14, no. 7, pp. 753–766, 2007. View at Publisher · View at Google Scholar · View at PubMed
  27. I. Nomura, B. Gao, M. Boguniewicz, M. A. Darst, J. B. Travers, and D. Y. M. Leung, “Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis,” Journal of Allergy and Clinical Immunology, vol. 112, no. 6, pp. 1195–1202, 2003. View at Publisher · View at Google Scholar · View at PubMed
  28. K. W. Christopherson II, A. F. Hood, J. B. Travers, H. Ramsey, and R. A. Hromas, “Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases,” Blood, vol. 101, no. 3, pp. 801–806, 2003. View at Publisher · View at Google Scholar · View at PubMed
  29. W. Weninger, H. S. Carlsen, M. Goodarzi, et al., “Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis,” Journal of Immunology, vol. 170, no. 9, pp. 4638–4648, 2003.
  30. N. Furusyo, H. Takeoka, K. Toyoda, et al., “Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS),” European Journal of Dermatology, vol. 17, no. 5, pp. 397–404, 2007.